BioCentury
ARTICLE | Company News

MDxHealth, Predictive Biosciences sales and marketing update

May 21, 2012 7:00 AM UTC

MDxHealth said in its 1Q12 earnings that partner Predictive launched its CertNDx Bladder Cancer Assay. The assay is a non-invasive diagnostic urine test combining matrix metalloproteinase 2 (MMP2), ...